Wejo Group Ltd

$ Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000186444823000125 Filed on May 22, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1

Balance Sheet

Concept	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$842.0K	$39.73M
YoY Change	-97.88%	3954.18%
Cash & Equivalents	$800.0K	$39.70M
Short-Term Investments
Other Short-Term Assets	$1.090M	$594.0K
YoY Change	83.5%	2.41%
Inventory
Prepaid Expenses	$2.731M	$11.62M
Receivables	$4.396M	$2.068M
Other Receivables	$1.651M	$2.295M
Total Short-Term Assets	$14.18M	$86.50M
YoY Change	-83.61%	230.26%
LONG-TERM ASSETS
Property, Plant & Equipment	$413.0K	$645.0K
YoY Change	-35.97%	66.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$747.0K	$471.0K
YoY Change	58.6%
Total Long-Term Assets	$8.403M	$13.24M
YoY Change	-36.51%	22.61%
TOTAL ASSETS
Total Short-Term Assets	$14.18M	$86.50M
Total Long-Term Assets	$8.403M	$13.24M
Total Assets	$22.58M	$99.73M
YoY Change	-77.36%	169.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$28.49M	$18.67M
YoY Change	52.64%	193.72%
Accrued Expenses	$34.16M	$17.26M
YoY Change	97.96%	118.62%
Deferred Revenue
YoY Change
Short-Term Debt	$17.68M	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$80.54M	$36.95M
YoY Change	118.0%	9.1%
LONG-TERM LIABILITIES
Long-Term Debt	$36.87M	$34.95M
YoY Change	5.51%
Other Long-Term Liabilities	$1.531M	$13.51M
YoY Change	-88.67%	-28.83%
Total Long-Term Liabilities	$1.531M	$48.46M
YoY Change	-96.84%	155.31%
TOTAL LIABILITIES
Total Short-Term Liabilities	$80.54M	$36.95M
Total Long-Term Liabilities	$1.531M	$48.46M
Total Liabilities	$123.4M	$85.40M
YoY Change	44.48%	-48.82%
SHAREHOLDERS EQUITY
Retained Earnings	-$560.2M	-$410.3M
YoY Change	36.53%	61.2%
Common Stock	$110.0K	$95.00K
YoY Change	15.79%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$100.8M	$14.33M
YoY Change
Total Liabilities & Shareholders Equity	$22.58M	$99.73M
YoY Change	-77.36%	169.66%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001864448
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-41091
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	Wejo Group Limited
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	D0
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1611674
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	Canon’s Court
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	22 Victoria Street
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Hamilton
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	HM12
CY2023Q1	dei	Entity Address Country EntityAddressCountry	BM
CY2023Q1	dei	City Area Code CityAreaCode	44 8002
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	343065
CY2023Q1	dei	Security12b Title Security12bTitle	Common Shares, $0.001 par value
CY2023Q1	dei	Trading Symbol TradingSymbol	WEJO
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	109900592	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	842000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8626000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4396000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4264000	usd
CY2023Q1	wejo	Forward Purchase Agreement Current ForwardPurchaseAgreementCurrent	1742000	usd
CY2022Q4	wejo	Forward Purchase Agreement Current ForwardPurchaseAgreementCurrent	2687000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7197000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6727000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	14177000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	22304000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	413000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	474000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	214000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	452000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7029000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7337000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	747000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	566000	usd
CY2023Q1	us-gaap	Assets Assets	22580000	usd
CY2022Q4	us-gaap	Assets Assets	31133000	usd
CY2023Q1	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	2352000	usd
CY2022Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	967000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	28492000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	21851000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	34164000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	26599000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	208000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	431000	usd
CY2023Q1	us-gaap	Secured Debt Current SecuredDebtCurrent	4054000	usd
CY2022Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	0	usd
CY2023Q1	us-gaap	Unsecured Debt Current UnsecuredDebtCurrent	2114000	usd
CY2022Q4	us-gaap	Unsecured Debt Current UnsecuredDebtCurrent	0	usd
CY2023Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	11510000	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	11390000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	80542000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	60271000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	21000	usd
CY2023Q1	us-gaap	Secured Long Term Debt SecuredLongTermDebt	36874000	usd
CY2022Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	36426000	usd
CY2023Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	586000	usd
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	594000	usd
CY2023Q1	wejo	Exchangeable Right Liability Noncurrent ExchangeableRightLiabilityNoncurrent	366000	usd
CY2022Q4	wejo	Exchangeable Right Liability Noncurrent ExchangeableRightLiabilityNoncurrent	403000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1531000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1838000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	123393000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	99896000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.001
CY2022Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	634000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	634000000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	109771513	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	109771513	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	109461562	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	109461562	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	110000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	109000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	447218000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	445478000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-560202000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-529204000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	12061000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	14854000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-100813000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-68763000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22580000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	31133000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3860000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	568000	usd
CY2023Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	4224000	usd
CY2022Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	1317000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9709000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7297000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4441000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5214000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10483000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17729000	usd
CY2023Q1	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	909000	usd
CY2022Q1	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	1098000	usd
CY2023Q1	us-gaap	Restructuring Costs RestructuringCosts	2385000	usd
CY2022Q1	us-gaap	Restructuring Costs RestructuringCosts	0	usd
CY2023Q1	wejo	Costs And Operating Expenses CostsAndOperatingExpenses	32151000	usd
CY2022Q1	wejo	Costs And Operating Expenses CostsAndOperatingExpenses	32655000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-28291000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-32087000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	1490000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	1243000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1179000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-6916000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-30960000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-40246000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	38000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	96000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-30998000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-40342000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-2793000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	2983000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-33791000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-37359000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.43
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.43
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	109681972	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	109681972	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	94300245	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	94300245	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-68763000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	100000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1641000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-2793000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-30998000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-100813000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	47694000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3000000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	996000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	2983000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-40342000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	14331000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-30998000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-40342000	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	449000	usd
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1243000	usd
CY2023Q1	wejo	Gain Loss In Estimated Fair Value On Financial Instruments Measured At Fair Value GainLossInEstimatedFairValueOnFinancialInstrumentsMeasuredAtFairValue	-666000	usd
CY2022Q1	wejo	Gain Loss In Estimated Fair Value On Financial Instruments Measured At Fair Value GainLossInEstimatedFairValueOnFinancialInstrumentsMeasuredAtFairValue	-3791000	usd
CY2023Q1	wejo	Realized Gain Loss On Issuance Of Financial Instruments RealizedGainLossOnIssuanceOfFinancialInstruments	-3370000	usd
CY2022Q1	wejo	Realized Gain Loss On Issuance Of Financial Instruments RealizedGainLossOnIssuanceOfFinancialInstruments	0	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	909000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1098000	usd
CY2023Q1	wejo	Expenses Related To Capital Raising Activities ExpensesRelatedToCapitalRaisingActivities	421000	usd
CY2022Q1	wejo	Expenses Related To Capital Raising Activities ExpensesRelatedToCapitalRaisingActivities	0	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1711000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	996000	usd
CY2023Q1	wejo	Non Cash Expense Settled By Issuance Of Commitment Shares NonCashExpenseSettledByIssuanceOfCommitmentShares	0	usd
CY2022Q1	wejo	Non Cash Expense Settled By Issuance Of Commitment Shares NonCashExpenseSettledByIssuanceOfCommitmentShares	3000000	usd
CY2023Q1	wejo	Share Based Payment Arrangement Noncash Payments ShareBasedPaymentArrangementNoncashPayments	100000	usd
CY2022Q1	wejo	Share Based Payment Arrangement Noncash Payments ShareBasedPaymentArrangementNoncashPayments	0	usd
CY2023Q1	wejo	Increase Decrease In Non Cash Lease Expense IncreaseDecreaseInNonCashLeaseExpense	-6000	usd
CY2022Q1	wejo	Increase Decrease In Non Cash Lease Expense IncreaseDecreaseInNonCashLeaseExpense	156000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1963000	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-4174000	usd
CY2023Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	45000	usd
CY2022Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	0	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	131000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	656000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-508000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1332000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	5909000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3839000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	0	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-155000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	162000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	480000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-352000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	0	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	7247000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-1407000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	21000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	96000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12256000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-23315000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	145000	usd
CY2023Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	328000	usd
CY2022Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	662000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	170000	usd
CY2022Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-498000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-807000	usd
CY2023Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	482000	usd
CY2022Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	usd
CY2023Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	482000	usd
CY2022Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0	usd
CY2023Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	275000	usd
CY2022Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	365000	usd
CY2022Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2023Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-3000	usd
CY2022Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	usd
CY2023Q1	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	0	usd
CY2022Q1	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	2085000	usd
CY2023Q1	wejo	Settlement Of Forward Purchase Agreement SettlementOfForwardPurchaseAgreement	45000	usd
CY2022Q1	wejo	Settlement Of Forward Purchase Agreement SettlementOfForwardPurchaseAgreement	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4902000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2085000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	68000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1384000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-7784000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-27591000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8626000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	67322000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	842000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	39731000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	usd
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	24000	usd
CY2023Q1	wejo	Business Combination Transaction Costs Included In Accounts Payable And Accrued Expenses BusinessCombinationTransactionCostsIncludedInAccountsPayableAndAccruedExpenses	6175000	usd
CY2022Q1	wejo	Business Combination Transaction Costs Included In Accounts Payable And Accrued Expenses BusinessCombinationTransactionCostsIncludedInAccountsPayableAndAccruedExpenses	6391000	usd
CY2023Q1	wejo	Capital Raising Transaction Costs Included In Accounts Payable And Accrued Expenses CapitalRaisingTransactionCostsIncludedInAccountsPayableAndAccruedExpenses	571000	usd
CY2022Q1	wejo	Capital Raising Transaction Costs Included In Accounts Payable And Accrued Expenses CapitalRaisingTransactionCostsIncludedInAccountsPayableAndAccruedExpenses	0	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3481000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-28300000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-119900000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12300000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-85500000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	800000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-560200000	usd
CY2023Q1	wejo	Working Capital WorkingCapital	-66400000	usd
CY2022Q1	wejo	Monthly Cash Utilization MonthlyCashUtilization	10000000	usd
CY2022Q4	wejo	Monthly Cash Utilization MonthlyCashUtilization	7000000	usd
CY2023Q1	wejo	Monthly Cash Utilization MonthlyCashUtilization	7000000	usd
CY2023Q1	wejo	Cumulative Proceeds From Bridge Capital CumulativeProceedsFromBridgeCapital	38000000	usd
CY2022Q4	wejo	Exchangeable Right Liability Noncurrent ExchangeableRightLiabilityNoncurrent	403000	usd
CY2022Q4	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	11390000	usd
CY2022Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	12730000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Use of Estimates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company believes the following critical accounting policies affect its more significant judgments and estimates used in the preparation of the unaudited condensed consolidated financial statements. Significant estimates and assumptions reflected in these unaudited condensed consolidated financial statements include, but are not limited to, the fair value of the common shares, Forward Purchase Agreement, Exchangeable Right Liability, Second Lien Securities Purchase Agreement, Unsecured Note Offering, GM Securities Purchase Agreement, warrant liabilities, income taxes, software development costs and the estimate of useful lives with respect to developed software, warrants, accounting for share-based payments, and timing of contractual obligations. The Company bases its estimates, judgments and assumptions on historical experience, its forecasts and budgets and other factors that the Company considers relevant. Other than as discussed herein, the significant accounting policies are described in Note 2 to the audited consolidated financial statements as of December 31, 2022 which are included in the Company’s Annual Report on Form 10-K as filed with the SEC on April 3,2023.</span></div>
CY2023Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk and Off-Balance Sheet Risk</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that subject the Company to credit risk consist of accounts receivable and cash. The Company places cash in established financial institutions. The Company controls credit risk related to accounts receivable through credit approvals, credit limits and monitoring procedures. The Company periodically assesses the financial strength of its customers and, based upon factors surrounding the credit risk, establishes an allowance, if required, for uncollectible accounts and, as a consequence, believes that its accounts receivable credit risk exposure beyond such allowance is limited. The Company has no significant off-balance-sheet risk or concentration of credit risk, such as foreign exchange contracts, options contracts, or other foreign hedging arrangements.</span></div>
CY2023Q1	wejo	Forward Purchase Agreement ForwardPurchaseAgreement	1742000	usd
CY2023Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	1742000	usd
CY2023Q1	us-gaap	Warrants Not Settleable In Cash Fair Value Disclosure WarrantsNotSettleableInCashFairValueDisclosure	586000	usd
CY2023Q1	wejo	Exchangeable Right Liability Noncurrent ExchangeableRightLiabilityNoncurrent	366000	usd
CY2023Q1	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	11510000	usd
CY2023Q1	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	22124000	usd
CY2022Q4	wejo	Forward Purchase Agreement ForwardPurchaseAgreement	2687000	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	2687000	usd
CY2022Q4	us-gaap	Warrants Not Settleable In Cash Fair Value Disclosure WarrantsNotSettleableInCashFairValueDisclosure	594000	usd
CY2023Q1	wejo	Exchangeable Right Liability Term ExchangeableRightLiabilityTerm	P3Y7M6D
CY2022Q4	wejo	Exchangeable Right Liability Term ExchangeableRightLiabilityTerm	P3Y10M24D
CY2023Q1	wejo	Debt Instrument Measurement Term DebtInstrumentMeasurementTerm	P0Y8M12D
CY2022	wejo	Debt Instrument Measurement Term DebtInstrumentMeasurementTerm	P1Y
CY2023Q1	wejo	Securities Purchase Agreements Warrants Term SecuritiesPurchaseAgreementsWarrantsTerm	P2Y8M12D
CY2022Q4	wejo	Securities Purchase Agreements Warrants Term SecuritiesPurchaseAgreementsWarrantsTerm	P3Y
CY2023Q1	wejo	Reduction Of Revenue Arising From Revenue Sharing ReductionOfRevenueArisingFromRevenueSharing	200000	usd
CY2022Q1	wejo	Reduction Of Revenue Arising From Revenue Sharing ReductionOfRevenueArisingFromRevenueSharing	1000000	usd
CY2023Q1	wejo	Forward Purchase Agreement ForwardPurchaseAgreement	1700000	usd
CY2022Q4	wejo	Forward Purchase Agreement Current ForwardPurchaseAgreementCurrent	2700000	usd
CY2023Q1	wejo	Unrealized Gain Loss On Forward Purchase Agreement UnrealizedGainLossOnForwardPurchaseAgreement	-100000	usd
CY2022Q1	wejo	Unrealized Gain Loss On Forward Purchase Agreement UnrealizedGainLossOnForwardPurchaseAgreement	-16700000	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2731000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2683000	usd
CY2023Q1	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	1272000	usd
CY2022Q4	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	1385000	usd
CY2023Q1	us-gaap	Prepaid Insurance PrepaidInsurance	1060000	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	1117000	usd
CY2023Q1	wejo	Research And Development Expenditure Credit Receivable Current ResearchAndDevelopmentExpenditureCreditReceivableCurrent	665000	usd
CY2022Q4	wejo	Prepaid Implementation Costs PrepaidImplementationCosts	662000	usd
CY2023Q1	wejo	Prepaid Implementation Costs PrepaidImplementationCosts	379000	usd
CY2022Q4	wejo	Research And Development Expenditure Credit Receivable Current ResearchAndDevelopmentExpenditureCreditReceivableCurrent	241000	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	1090000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	639000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7197000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6727000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1502000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1460000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1089000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	986000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	413000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	474000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	100000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	100000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	26235000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	19206000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7029000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	25181000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	17844000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7337000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	2422000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2757000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1840000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	10000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	0	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7029000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	13695000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	10995000	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	4653000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	6207000	usd
CY2023Q1	wejo	Accrued Development And Technology Cost Current AccruedDevelopmentAndTechnologyCostCurrent	5903000	usd
CY2022Q4	wejo	Accrued Development And Technology Cost Current AccruedDevelopmentAndTechnologyCostCurrent	4312000	usd
CY2023Q1	wejo	Accrued Revenue Share Costs AccruedRevenueShareCosts	5416000	usd
CY2022Q4	wejo	Accrued Revenue Share Costs AccruedRevenueShareCosts	3045000	usd
CY2023Q1	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	2085000	usd
CY2022Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	0	usd
CY2023Q1	us-gaap	Litigation Reserve Current LitigationReserveCurrent	1722000	usd
CY2022Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	1413000	usd
CY2023Q1	wejo	Accrued Marketing And Commission Cost Current AccruedMarketingAndCommissionCostCurrent	104000	usd
CY2022Q4	wejo	Accrued Marketing And Commission Cost Current AccruedMarketingAndCommissionCostCurrent	218000	usd
CY2023Q1	us-gaap	Deferred Income DeferredIncome	125000	usd
CY2022Q4	us-gaap	Deferred Income DeferredIncome	200000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	461000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	209000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	34164000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	26599000	usd
CY2023Q1	wejo	Gain Loss On Fair Value Of Securities Purchase Agreement GainLossOnFairValueOfSecuritiesPurchaseAgreement	-157000	usd
CY2023Q1	wejo	Gain Loss On Issuance Of Second Lien Securities Purchase Agreement GainLossOnIssuanceOfSecondLienSecuritiesPurchaseAgreement	-2188000	usd
CY2022Q1	wejo	Gain Loss On Issuance Of Second Lien Securities Purchase Agreement GainLossOnIssuanceOfSecondLienSecuritiesPurchaseAgreement	0	usd
CY2023Q1	wejo	Gain Loss On Issuance Of Issuance Of Unsecured Note Offering GainLossOnIssuanceOfIssuanceOfUnsecuredNoteOffering	-1182000	usd
CY2022Q1	wejo	Gain Loss On Issuance Of Issuance Of Unsecured Note Offering GainLossOnIssuanceOfIssuanceOfUnsecuredNoteOffering	0	usd
CY2023Q1	wejo	Unrealized Gain Loss On Fair Value Of Second Lien Securities Purchase Agreement UnrealizedGainLossOnFairValueOfSecondLienSecuritiesPurchaseAgreement	-418000	usd
CY2022Q1	wejo	Unrealized Gain Loss On Fair Value Of Second Lien Securities Purchase Agreement UnrealizedGainLossOnFairValueOfSecondLienSecuritiesPurchaseAgreement	0	usd
CY2023Q1	wejo	Unrealized Gain Loss On Fair Value Of Unsecured Note Offering UnrealizedGainLossOnFairValueOfUnsecuredNoteOffering	4000	usd
CY2022Q1	wejo	Unrealized Gain Loss On Fair Value Of Unsecured Note Offering UnrealizedGainLossOnFairValueOfUnsecuredNoteOffering	0	usd
CY2023Q1	wejo	Unrealized Gain Loss On Warrants UnrealizedGainLossOnWarrants	8000	usd
CY2022Q1	wejo	Unrealized Gain Loss On Warrants UnrealizedGainLossOnWarrants	5933000	usd
CY2023Q1	wejo	Unrealized Gain Loss On Forward Purchase Agreement UnrealizedGainLossOnForwardPurchaseAgreement	-140000	usd
CY2022Q1	wejo	Unrealized Gain Loss On Forward Purchase Agreement UnrealizedGainLossOnForwardPurchaseAgreement	-16704000	usd
CY2022Q1	wejo	Gain Loss On Fair Value Of Securities Purchase Agreement GainLossOnFairValueOfSecuritiesPurchaseAgreement	0	usd
CY2023Q1	wejo	Unrealized Gain Loss On Exchangeable Right Liability UnrealizedGainLossOnExchangeableRightLiability	37000	usd
CY2022Q1	wejo	Unrealized Gain Loss On Exchangeable Right Liability UnrealizedGainLossOnExchangeableRightLiability	6980000	usd
CY2023Q1	wejo	Other Net OtherNet	2857000	usd
CY2022Q1	wejo	Other Net OtherNet	-3125000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1179000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-6916000	usd
CY2023Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	11500000	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	11400000	usd
CY2022Q4	wejo	Warrant Liability Non Current WarrantLiabilityNonCurrent	300000	usd
CY2023Q1	wejo	Gain Loss On Fair Value Of Securities Purchase Agreement GainLossOnFairValueOfSecuritiesPurchaseAgreement	-200000	usd
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.43
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1711000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	996000	usd
CY2023Q1	us-gaap	Restructuring Costs RestructuringCosts	2400000	usd
CY2023Q1	us-gaap	Restructuring And Related Cost Expected Cost1 RestructuringAndRelatedCostExpectedCost1	200000	usd
CY2022Q4	us-gaap	Restructuring Reserve RestructuringReserve	0	usd
CY2023Q1	us-gaap	Payments For Restructuring PaymentsForRestructuring	102000	usd
CY2023Q1	us-gaap	Restructuring Reserve RestructuringReserve	2283000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-30998000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-40342000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-30998000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-30998000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-40342000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-40342000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	109681972	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	109681972	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	94300245	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	94300245	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.43
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	54717550	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	29113034	shares
CY2022	wejo	Increase Decrease In Right Of Use Asset IncreaseDecreaseInRightOfUseAsset	-2100000	usd
CY2022	wejo	Increase Decrease In Operating Lease Liability Current IncreaseDecreaseInOperatingLeaseLiabilityCurrent	-400000	usd
CY2022	wejo	Increase Decrease In Operating Lease Liability Noncurrent IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent	-1800000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.11
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	200000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	210000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	210000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	208000	usd
CY2022Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	1400000	usd
CY2022Q4	us-gaap	Litigation Reserve Noncurrent LitigationReserveNoncurrent	1800000	usd
CY2023Q1	us-gaap	Litigation Reserve Current LitigationReserveCurrent	1700000	usd
CY2023Q1	us-gaap	Litigation Reserve Noncurrent LitigationReserveNoncurrent	1500000	usd

Files In Submission

Name	View Source	Status
0001864448-23-000125-index-headers.html	Edgar Link	pending
0001864448-23-000125-index.html	Edgar Link	pending
0001864448-23-000125.txt	Edgar Link	pending
0001864448-23-000125-xbrl.zip	Edgar Link	pending
a1011-formoftemporaryret.htm	Edgar Link	pending
a1011-formoftemporaryret001.jpg	Edgar Link	pending
a1011-formoftemporaryret002.jpg	Edgar Link	pending
a1011-formoftemporaryret003.jpg	Edgar Link	pending
a1011-formoftemporaryret004.jpg	Edgar Link	pending
a1011-formoftemporaryret005.jpg	Edgar Link	pending
a1011-formoftemporaryret006.jpg	Edgar Link	pending
a1011-formoftemporaryret007.jpg	Edgar Link	pending
a1011-formoftemporaryret008.jpg	Edgar Link	pending
a1011-formoftemporaryret009.jpg	Edgar Link	pending
a1011-formoftemporaryret010.jpg	Edgar Link	pending
a108-wejoxthirdamendment.htm	Edgar Link	pending
a108-wejoxthirdamendment001.jpg	Edgar Link	pending
a108-wejoxthirdamendment002.jpg	Edgar Link	pending
a108-wejoxthirdamendment003.jpg	Edgar Link	pending
a108-wejoxthirdamendment004.jpg	Edgar Link	pending
exhibit311formcertificat.htm	Edgar Link	pending
exhibit311formcertificat001.jpg	Edgar Link	pending
exhibit312formcertificat.htm	Edgar Link	pending
exhibit312formcertificat001.jpg	Edgar Link	pending
exhibit321formcertificat.htm	Edgar Link	pending
exhibit321formcertificat001.jpg	Edgar Link	pending
exhibit322formcertificat.htm	Edgar Link	pending
exhibit322formcertificat001.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
wejo-20230331.htm	Edgar Link	pending
wejo-20230331.xsd	Edgar Link	pending
wejo-20230331_g1.jpg	Edgar Link	pending
wejo-20230331_cal.xml	Edgar Link	unprocessable
wejo-20230331_def.xml	Edgar Link	unprocessable
wejo-20230331_lab.xml	Edgar Link	unprocessable
wejo-20230331_pre.xml	Edgar Link	unprocessable
wejo-20230331_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

Wejo Group Ltd

2023 Q2 Form 10-Q Financial Statement

#000186444823000125 Filed on May 22, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission